Etoposide in Langerhans cell histiocytosis in children: A preliminary experience

Pediatric Hematology and Oncology

Volumn 13, Issue 2, 1996, Pages 159-162

  Basade, M M ^a   Nair, C N ^a   Kurkure, P A ^a   Pai, S K ^a   Advani, S H ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

etoposide; Langerhans histiocytosis

Indexed keywords

ETOPOSIDE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; FEMALE; HISTIOCYTOSIS; HUMAN; LANGERHANS CELL; LIVER DYSFUNCTION; MALE; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 0029878993     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.3109/08880019609030806     Document Type: Article

References (17)

1. Ishii E, Watanabe S. Biochemistry and biology of the Langerhans cell: Histiocytosis X. Hematol Oncol Clin North Am. 1987;1:99-118.
2. Greenberger J, Cassady JR, Jaffe N, et al. Radiation therapy in patients with histiocytosis: Management of diabetes insipidus and bone lesions. Int J Radiat Oncol Biol Phys. 1979;5:1749-1755.
3. Lavin TP, Osband ME. Evaluating the role of therapy in histiocytosis-X: Clinical studies, staging, and scoring. Hematol Oncol Clin North Am. 1987;1:35-47.
4. Lahey ME. Histiocytosis X - comparison of three treatment regimens. J Pediatr. 1975;87:179-183.
5. Ladisch S. Histiocytosis. In: Willoughby M, Siegel SE, eds. Hematology and Oncology, Pediatrics 1. London: Butterworth Scientific, 1983:95-109.
6. Jones B, Kung F, Chevalier L, et al. Chemotherapy of reticuloendotheliosis. Comparison of methotrexate plus prednisolone vs. vincristine plus prednisolone. Cancer. 1974;34:1011-1017.
7. Smith PJ, Ekert H, Campbell PE. Improved prognosis in disseminated histiocytosis. Med Pediatr Oncol. 1976;2:371-377.
8. Komp DM, Vietti TJ, Berry DH, et al. Combination chemotherapy in histiocytosis X. Med Pediatr Oncol. 1977;3:267-273.
9. Starling KA. Chemotherapy of histiocytosis. Am J Pediatr Hematol Oncol. 1981;3:157-160.
10. Viana MB, Oliveira BM, Silva CM, et al. Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X). Med Pediatr Oncol. 1991;19:289-294.
11. Ishii E, Matsuzaki A, Okamura J, et al. Treatment of Langerhans cell histiocytosis in children with etoposide. Am J Clin Oncol. 1992;15:515-517.
12. Broadbent V, Pritchard J, Yeomans E. Etoposide (VP-16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X). Med Pediatr Oncol. 1989;17:97-100.
13. Raney Jr RB, D'Angio GJ. Langerhans cell histiocytosis (histiocytosis X). Experience at the Children's Hospital of Philadelphia, 1970-1984. Med Pediatr Oncol. 1989;17:20-28.
14. Broadbent V, Pritchard J. Histiocytosis X. Current controversies. Arch Dis Child. 1985;60:605-607.
15. Starling K. Chemotherapy in histiocytosis X. Hematol Oncol Clin North Am. 1987;1:119-122.
16. Ceci A, De Terlizzi M, Balducci D, et al. Recurrent childhood Langerhans cell histiocytosis: A multicentre study with etoposide. Presented at Third Annual Meeting of the Histiocyte Society. Med Pediatr Oncol. 1988;16:146.
17. Gadner H, Heitger A, Grois N, et al. A treatment strategy for disseminated Langerhans cell histiocytosis. Med Pediatr Oncol. 1994;23:72-80.